11 Analysts Assess Taysha Gene Therapies: What You Need To Know
11 Analysts Assess Taysha Gene Therapies: What You Need To Know
11 位分析師評估 Taysha 基因療法：你需要知道的
Throughout the last three months, 11 analysts have evaluated Taysha Gene Therapies (NASDAQ:TSHA), offering a diverse set of opinions from bullish to bearish.
在過去的三個月中，有11位分析師對Taysha Gene Therapies（納斯達克股票代碼：TSHA）進行了評估，提供了從看漲到看跌的不同觀點。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您將找到他們最近的評級摘要，揭示了過去30天中情緒的變化，並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $6.82, a high estimate of $9.00, and a low estimate of $5.00. Marking an increase of 36.4%, the current average surpasses the previous average price target of $5.00.
分析師分析的12個月目標股價提供了見解，平均目標價爲6.82美元，最高估計爲9.00美元，低估值爲5.00美元。當前的平均價格上漲了36.4％，超過了之前的平均目標股價5.00美元。
Breaking Down Analyst Ratings: A Detailed Examination
分解分析師評級：詳細審查
The standing of Taysha Gene...
通過對分析...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。